1. |
孙丽莹, 朱志军, 魏林, 等. ABO血型不相容肝移植15例临床分析. 中华器官移植杂志, 2015, 36(8): 477-480.
|
2. |
Hashimoto T, Kondo S, Suzuki T, et al. Strategy for ABO-incompatible living-related liver transplantation. Transplant Proc, 2000, 32(7): 2104-2106.
|
3. |
Varela-Fascinetto G, Treacy SJ, Lillehei CW, et al. Long-term results in pediatric ABO-incompatible liver transplantation. Transplant Proc, 1999, 31(1-2): 467-468.
|
4. |
Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation, 2004, 77(3): 403-411.
|
5. |
Honda M, Sugawara Y, Kadohisa M, et al. Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation. Transplantation, 2018, 102(10): 1702-1709.
|
6. |
Kim JM, Kwon CH, Joh JW, et al. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. J Hepatol, 2013, 59(6): 1215-1222.
|
7. |
Ikegami T, Shirabe K, Soejima Y, et al. Feasibility of ABO-incompatible living donor liver transplantation in the rituximab era. Liver Transpl, 2010, 16(11): 1332-1333.
|
8. |
Tanabe M, Kawachi S, Obara H, et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Invest, 2010, 40(10): 943-949.
|
9. |
Kim JD, Choi DL, Han YS. Fourteen successful consecutive cases of ABO-incompatible living donor liver transplantation: new simplified intravenous immunoglobulin protocol without local infusion therapy. Transplant Proc, 2014, 46(3): 754-757.
|
10. |
Yoshizawa A, Sakamoto S, Ogawa K, et al. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen. Transplant Proc, 2005, 37(4): 1718-1719.
|
11. |
Egawa H. Challenge to ABO blood type barrier in living donor liver transplantation. Hepatobiliary Pancreat Dis Int, 2020, 19(4): 342-348.
|
12. |
Egawa H, Umeshita K, Uemoto S. Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation. J Hepatobiliary Pancreat Sci, 2017, 24(2): 89-94.
|
13. |
Tokodai K, Kumagai-Braesch M, Karadagi A, et al. Blood group antigen expression in isolated human liver cells in preparation for implementing clinical ABO-incompatible hepatocyte transplantation. J Clin Exp Hepatol, 2020, 10(2): 106-113.
|
14. |
Haga H, Egawa H, Fujimoto Y, et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl, 2006, 12(3): 457-464.
|
15. |
Kobayashi T. Standardization of the assay method for anti-A/B antibody titers and its problems. International Congress Series, 2006, 1292: 3-7.
|
16. |
Egawa H, Ohmori K, Haga H, et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl, 2007, 13(4): 579-588.
|